Key result
Combined mitral and tricuspid TEER achieves high procedural success with low complications in concomitant MR and TR.
Why the study?
Moderate-to-severe MR and TR frequently coexist in patients with heart failure and confer a worse prognosis, yet current guidelines address mitral and tricuspid TEER separately and provide no clear recommendations for combined TEER.
Does combined mitral and tricuspid transcatheter edge-to-edge repair (concomitant or staged) improve survival, heart failure hospitalization, and functional outcomes compared to isolated TEER in patients with concomitant mitral and tricuspid regurgitation?
Does combined mitral and tricuspid transcatheter edge-to-edge repair (concomitant or staged) improve survival, heart failure hospitalization, and functional outcomes compared to isolated TEER in patients with concomitant mitral and tricuspid regurgitation?
This comprehensive review synthesizes observational evidence showing that combined mitral and tricuspid TEER is safe and feasible in patients with dual-valve regurgitation, proposing an individualized decision-making framework between concomitant and staged procedures based on tricuspid annular dilation, atrial fibrillation, and right ventricular function.
Answers are grounded in this paper and cite their sources.
Supports individualized concomitant or staged TEER in selected MR/TR patients; leaves open survival and hospitalization benefits versus isolated repair.
Transcatheter edge-to-edge repair (TEER) has become an effective treatment option for mitral regurgitation (MR) and tricuspid regurgitation (TR), with high procedural success and low complication rates. Moderate-to-severe MR and TR coexist in approximately 11% of patients with heart failure, and patients with both conditions have a worse prognosis than those with either lesion alone. Current guidelines recommend treatment of concomitant TR during mitral valve surgery when tricuspid annular dilation is present. However, there are no clear recommendations for combined TEER, as mitral and tricuspid TEER are addressed separately in the guidelines. In this review, the available evidence and current clinical approaches to combined vs. isolated TEER across different combinations and severities of MR and TR were evaluated.
No takes yet. Share an insight, caveat, or question.
Bozbaş et al. (2026) conducted a review in Concomitant mitral regurgitation and tricuspid regurgitation. Combined mitral and tricuspid transcatheter edge-to-edge repair (TEER) vs. Isolated mitral or tricuspid TEER, or staged TEER was evaluated. Combined mitral and tricuspid TEER is feasible with high procedural success and low complication rates in selected patients with concomitant MR and TR, though randomized trials are needed.
Synapse has enriched 10 related papers. Consider them for comparative context: